Study highlights the role of the immune system in Parkinson's Date 22 June 2017 New research, reported in the scientific journal Nature, suggests that the immune system plays an important role in the progression of Parkinson's.
Low fat dairy products linked to Parkinson's Date 8 June 2017 Higher consumption of low fat dairy products such as milk, butter, cheese and yoghurt is linked to a modest increase in risk of Parkinson’s, according to new research.
Reprogramming brain cells to reverse Parkinson’s Date 10 April 2017 New research published in Nature Biotechnology shows that it may be possible to reprogramme cells inside the brain to reverse the symptoms of Parkinson's.
Welcome to our new Deputy Director of Research Date 9 March 2017 We're excited to announce that Professor David Dexter has joined us as our new Deputy Director of Research.
Positive results from trial of inhalable levodopa Date 10 February 2017 Results from a clinical trial suggest an inhalable form of levodopa could help people with Parkinson's who experience 'off periods'.
Deep-brain ultrasound therapy used to treat tremor Date 12 December 2016 A research team at Imperial College are testing the use of high-intensity, focused ultrasound waves for the first time in the UK to treat tremor.
A brain scan that could diagnose Parkinson's Date 29 November 2016 Research funded by Parkinson's UK has found MRIs, a type of brain scan, to be 'highly accurate' at identifying mild to moderate Parkinson's.
Further evidence that Parkinson's starts in the gut Date 24 November 2016 An abnormal protein normally found in brain cells affected in Parkinson's can move from the gut to the brain, according to new research.
New drug treatment Opicapone launches in UK Date 18 October 2016 A new drug treatment for Parkinson's, opicapone, has launched in the UK. It could prolong the effect of levodopa and reduce the number of tablets required.
New research highlights importance of cardiovascular health in Parkinson's Date 29 September 2016 New research shows that people recently diagnosed with Parkinson's who are at high or medium risk of cardiovascular disease tend to have more problems with walking and memory.
